Lecture 69 - pathology of cervical cancers Flashcards
High risk HPV
Low Risk HPV
High: 16, 18, 31, 33
Low: 6, 11
______-age women are more susceptible to HPV infections
______% of HPV infections persist longer than 2 years
younger women – higher prevelance of HPV infection,
10%
what is HPV protein is used to generate the HPV vaccine?
What HPV proteins are oncogenic ? respected tumor suppressors which are suppressed?
what cellular marker can help determine if there is an HPV integrated infection?
L1 gene – used to generate the vaccine
E6 - blocks p53
E7 - blocks Rb
P16 = downregulared by Rb; therefore upregualted in HPV integrated infection
Hierarchy of pap smear cytological findings according the bethesda critera;
what if the findings are kind of ambiguous
LSIL – low grade squamous intraepithelial lesion
HSIL – high grade
ASCUS – atypical squamous cells of undeteremined significance
ASCH – Atypical squamous; cannot exclude HSIL
ASCUS is suggestive for ___
ASC H is suggestive for___
appropriate management for each
ASCUS - LSIL suggestive changes;
Managed: HPV testing; If postive proceed with colposcopy and bx
ASC H – HSIL suggestive;
Managed: Colposcopy and bx
LSIL –
likely progression?
what are the cellular changes due to ?
____%positive for high risk HPV
Management:
10% progress to HSIL
cell changes: Productive HPV infection, but this is very likely to regress
80% positive for high risk HPV
Management: Pap testing; colposcopy + biopsy
HSIL
____% progress to SCC
Cell changes due to ____
____% postiive to high risk HPV
management:
10% progress to SCC
Cellular change due to Integrated HPV virus
100% positive for high risk HPV
management:
Colposcopy, Bx
LEEP vs Cold Knife Cone
Most common type of cervical cancer
SCC
Additional Type of cervical cancer
associated with what form of HPV
what is the screening method for this type of cancer?
Cervical Adenocarcinoma
HPV 18
Prognosis is worse than SCC
No screening. Pap is not sensitive enough
current recommendations for Pap smears
when do you stop testing?
Age 21 and over – every three years
Women 30+ – every 3 years, or every 5 years if HPV DNA co -testing negative
Stop testing: 65 yo with adquanate prior negative testing